128 related articles for article (PubMed ID: 17762927)
1. Objective response to radiation therapy and long-term survival of patients with WHO grade II astrocytic gliomas with known LOH 1p/19q status.
Fathi AR; Vassella E; Arnold M; Curschmann J; Reinert M; Vajtai I; Weis J; Deiana G; Mariani L
Strahlenther Onkol; 2007 Sep; 183(9):517-22. PubMed ID: 17762927
[TBL] [Abstract][Full Text] [Related]
2. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.
Okamoto Y; Di Patre PL; Burkhard C; Horstmann S; Jourde B; Fahey M; Schüler D; Probst-Hensch NM; Yasargil MG; Yonekawa Y; Lütolf UM; Kleihues P; Ohgaki H
Acta Neuropathol; 2004 Jul; 108(1):49-56. PubMed ID: 15118874
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy.
Mariani L; Deiana G; Vassella E; Fathi AR; Murtin C; Arnold M; Vajtai I; Weis J; Siegenthaler P; Schobesberger M; Reinert MM
J Clin Oncol; 2006 Oct; 24(29):4758-63. PubMed ID: 16966689
[TBL] [Abstract][Full Text] [Related]
4. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.
Watanabe T; Nakamura M; Kros JM; Burkhard C; Yonekawa Y; Kleihues P; Ohgaki H
Acta Neuropathol; 2002 Mar; 103(3):267-75. PubMed ID: 11907807
[TBL] [Abstract][Full Text] [Related]
5. Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.
Jha P; Agarwal S; Pathak P; Srivastava A; Suri V; Sharma MC; Chosdol K; Srivastava T; Gupta D; Gupta A; Suri A; Sarkar C
Cancer Genet Cytogenet; 2010 Apr; 198(2):126-34. PubMed ID: 20362227
[TBL] [Abstract][Full Text] [Related]
6. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?
Weller M; Berger H; Hartmann C; Schramm J; Westphal M; Simon M; Goldbrunner R; Krex D; Steinbach JP; Ostertag CB; Loeffler M; Pietsch T; von Deimling A;
Clin Cancer Res; 2007 Dec; 13(23):6933-7. PubMed ID: 18056167
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy in supratentorial gliomas. A study of 821 cases.
Heesters M; Molenaar W; Go GK
Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
[TBL] [Abstract][Full Text] [Related]
8. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].
Born PW; Broholm H; Laursen H
Ugeskr Laeger; 2006 Oct; 168(44):3813-6. PubMed ID: 17118240
[TBL] [Abstract][Full Text] [Related]
9. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M
Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
Ständer M; Peraud A; Leroch B; Kreth FW
Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
Stege EM; Kros JM; de Bruin HG; Enting RH; van Heuvel I; Looijenga LH; van der Rijt CD; Smitt PA; van den Bent MJ
Cancer; 2005 Feb; 103(4):802-9. PubMed ID: 15637687
[TBL] [Abstract][Full Text] [Related]
12. Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas?
Gadji M; Fortin D; Tsanaclis AM; Drouin R
Cancer Genet Cytogenet; 2009 Oct; 194(1):12-22. PubMed ID: 19737649
[TBL] [Abstract][Full Text] [Related]
13. Calcification on CT is a simple and valuable preoperative indicator of 1p/19q loss of heterozygosity in supratentorial brain tumors that are suspected grade II and III gliomas.
Saito T; Muragaki Y; Maruyama T; Komori T; Tamura M; Nitta M; Tsuzuki S; Kawamata T
Brain Tumor Pathol; 2016 Jul; 33(3):175-82. PubMed ID: 26849373
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP
Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770
[TBL] [Abstract][Full Text] [Related]
15. Reclassification of oligoastrocytomas by loss of heterozygosity studies.
Eoli M; Bissola L; Bruzzone MG; Pollo B; Maccagnano C; De Simone T; Valletta L; Silvani A; Bianchessi D; Broggi G; Boiardi A; Finocchiaro G
Int J Cancer; 2006 Jul; 119(1):84-90. PubMed ID: 16432842
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors.
Scheie D; Andresen PA; Cvancarova M; Bø AS; Helseth E; Skullerud K; Beiske K
Am J Surg Pathol; 2006 Jul; 30(7):828-37. PubMed ID: 16819324
[TBL] [Abstract][Full Text] [Related]
17. Association between fluorine-18-labeled fluorodeoxyglucose uptake and 1p and 19q loss of heterozygosity in World Health Organization Grade II gliomas.
Stockhammer F; Thomale UW; Plotkin M; Hartmann C; Von Deimling A
J Neurosurg; 2007 Apr; 106(4):633-7. PubMed ID: 17432715
[TBL] [Abstract][Full Text] [Related]
18. High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion.
Law M; Brodsky JE; Babb J; Rosenblum M; Miller DC; Zagzag D; Gruber ML; Johnson G
J Magn Reson Imaging; 2007 Jun; 25(6):1113-9. PubMed ID: 17520715
[TBL] [Abstract][Full Text] [Related]
19. Association of chromosome 10 losses and negative prognosis in oligoastrocytomas.
Bissola L; Eoli M; Pollo B; Merciai BM; Silvani A; Salsano E; Maccagnano C; Bruzzone MG; Fuhrman Conti AM; Solero CL; Giombini S; Broggi G; Boiardi A; Finocchiaro G
Ann Neurol; 2002 Dec; 52(6):842-5. PubMed ID: 12447941
[TBL] [Abstract][Full Text] [Related]
20. Novel molecular stereotactic biopsy procedures reveal intratumoral homogeneity of loss of heterozygosity of 1p/19q and TP53 mutations in World Health Organization grade II gliomas.
Thon N; Eigenbrod S; Grasbon-Frodl EM; Ruiter M; Mehrkens JH; Kreth S; Tonn JC; Kretzschmar HA; Kreth FW
J Neuropathol Exp Neurol; 2009 Nov; 68(11):1219-28. PubMed ID: 19816195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
